International
The Morning Science

What science found today

‹
 

Research

Alzheimer's Light and Sound Stimulation Therapy Misses Main Goal in Pivotal Trial

MedPage Today ·

Alzheimer's Light and Sound Stimulation Therapy Misses Main Goal in Pivotal Trial

The Brief

  • A pivotal trial (HOPE) of an Alzheimer's therapy delivering 40 Hz light and sound stimulation did not meet its primary endpoint.
  • The therapy was designed to engage gamma-frequency brain activity.
  • The result was reported by MedPage Today from CTAD meeting coverage on 2026-11-20.

Why it matters

A large pivotal trial failing its primary endpoint weakens the case for 40 Hz sensory stimulation as a treatment for Alzheimer's disease, and shapes how researchers and clinicians judge similar non-drug approaches.

Who’s affected

  • Alzheimer's researchers and clinicians
  • patients and caregivers following non-drug dementia therapies

(MedPage Today) -- A novel Alzheimer's therapy platform that delivered 40 Hz light and sound stimulation to engage gamma-frequency brain activity did not meet its primary endpoint, the HOPE pivotal study showed. In the primary analysis population...

Timeline

  1. MedPage Today reports that the HOPE pivotal study missed its primary endpoint

  2. MedPageToday.com - medical news for physicians

    Alzheimer's Light and Sound Stimulation Therapy Misses Main Goal in Pivotal Trial

How do you feel about this?

0 Comments

    Alzheimer's Light and Sound Stimulation Therapy Misses Main Goal in Pivotal Trial – The Morning Science